Comment on Montagnani et al. Optimization of RAASi Therapy with New Potassium Binders for Patients with Heart Failure and Hyperkalemia: Rapid Review and Meta-Analysis.


Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
13 May 2022
Historique:
received: 15 03 2022
accepted: 27 04 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

The recent rapid review and meta-analysis by Montagnani et al. [...].

Identifiants

pubmed: 35628883
pii: jcm11102755
doi: 10.3390/jcm11102755
pmc: PMC9145906
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : AstraZeneca
ID : N/A

Références

Am J Nephrol. 2019;50(6):473-480
pubmed: 31658466
Curr Ther Res Clin Exp. 2021 Jul 05;95:100635
pubmed: 34367383
Curr Ther Res Clin Exp. 2021 Nov 02;95:100651
pubmed: 34849179
Kidney Int. 2020 Jan;97(1):42-61
pubmed: 31706619
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):798-809
pubmed: 31110051
J Am Coll Cardiol. 2021 Feb 16;77(6):772-810
pubmed: 33446410
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
J Clin Med. 2021 Nov 23;10(23):
pubmed: 34884184
Kidney Int. 2021 Mar;99(3S):S1-S87
pubmed: 33637192

Auteurs

Donna Zarzuela (D)

Global Medical Affairs, AstraZeneca, Gaithersburg, MD 20878, USA.

Alex Chin (A)

Global Medical Affairs, AstraZeneca, Gaithersburg, MD 20878, USA.

Classifications MeSH